$7.08
0.060.85%
Pre-Market: 8:05 AM EDT
15 minutes delayed
Aurinia Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Aurinia Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-01 | $0.01 | $0.01 | 0.00 % |
Mar 2024 | 2024-05-02 | $-0.03 | $-0.14 | 78.6 % |
Dec 2023 | 2024-02-15 | $-0.19 | $-0.16 | -18.8 % |
Sep 2023 | 2023-11-02 | $-0.09 | $-0.17 | 47.1 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-01 | $57.19M | $55.05M | 3.89 % |
Mar 2024 | 2024-05-02 | $50.30M | $47.45M | 6.01 % |
Dec 2023 | 2024-02-15 | $45.10M | $44.45M | 1.45 % |
Sep 2023 | 2023-11-02 | $54.52M | $38.50M | 41.6 % |
Aurinia Pharmaceuticals (AUPH) is scheduled to report earnings on October 31, 2024. The last reported earnings were for reported on August 1, 2024 for Q2.
The Actual EPS was $0.01, which hit the estimate of $0.01.
The Actual Revenue was $57.2M, which beat the estimate of $55M.
Browse earnings estimates, EPS, and revenue on all stocks.